ImmuPharma PLC (IMM)

Industry Biotechnology

This stock can be held in an Investment ISA, SIPP and Investment Account

Sell

6.00p

Buy

6.20p

arrow-up0.00p (+0.00%)

Prices updated at 12 Dec 2025, 17:29 GMT

Prices minimum 15 mins delay

Prices in GBX

ImmuPharma PLC is a drug discovery and development company. The company along with its subsidiaries is engaged in the research and development of novel drugs based on peptide therapeutics to treat serious medical conditions including autoimmune diseases.

FTSE All-Share

-0.48%

LSE

Important documents: Please ensure that you have read the Pre-sale Illustrations document & Doing Business with Fidelity document (incorporating the Fidelity Client Terms) and

Our Investment Fees and Charges.

In the news

Sharecast service unavailable

Press releases

24 Nov 2025

04 Nov 2025

27 Oct 2025

23 Oct 2025

13 Oct 2025

06 Oct 2025

17 Sep 2025

11 Sep 2025

01 Sep 2025

Key dates

	Forecast date
Half yearly results	Aug 2026
Annual general meeting	Jun 2026
Final results	May 2026
Annual report	May 2026

	Previous date
Half yearly results	Aug 2025
Annual general meeting	Jun 2025
Final results	May 2025
Annual report	May 2025

Company reports

31 Dec 2022

Annual Report

Quarterly Report

Important Information

Investment values, and income from investments, can go down as well as up, so you may get back less than you invest. This is not a personal recommendation for a specific investment. If you're not sure which investments are suitable for you, consult Fidelity's advisers or another authorised financial adviser. The information contained herein: is proprietary to Morningstar and/or its content providers; may not be copied or distributed; and is not warranted to be accurate, complete or timely. Neither Morningstar nor its content providers are responsible for any damages or losses arising from any use of this information.